Professor Shen Zheyu graduated from the Institute of Process Engineering, Chinese Academy of Sciences in 2008 with a doctorate. After graduation, he worked full-time in Gunma University in Japan, University of Adelaide in Australia, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, and National Institutes of Health in the United States. In August 2019, he was a high-level overseas talent (third level) Introduced Southern Medical University, served as a professor, and established a research group. In response to the country’s strategic needs for tumor diagnosis and treatment, Professor Shen Zheyu has long been committed to the research of tumor nanodiagnosis and therapy, focusing on the design, controllable construction and effective regulation of nanomaterials, and modifying inorganic nanometers through organic molecules. Materials, adjust the physical properties, chemical properties or microscopic state changes of composite nanomaterials, explore ways to improve the water phase stability, biocompatibility, tumor targeting of organic-inorganic composite nanomaterials, and realize tumor diagnosis and treatment. A series of research results have been achieved. Based on these results, Professor Shen Zheyu has published more than 70 papers in SCI journals such as Nat. Commun., Chem. Soc. Rev., Adv. Mater., ACS Nano, Small, and Biomaterials, among which the first or corresponding author’s papers Of 36 papers, 3 papers were rated as ESI highly cited papers. In the past five years, there are 7 papers with an impact factor greater than 20, including 3 papers by the first author; in the past five years, a total of 25 papers with an impact factor greater than 10, including 10 papers by the first author or co-corresponding author. The published papers have been positively cited more than 2,300 times, and the H index = 28 (Google Scholar). 16 Chinese invention patents have been applied for (13 of which have been authorized). He has presided over 5 national-level projects, won the Outstanding Youth Science Fund of Zhejiang Natural Science Foundation, was selected as a member of the Youth Innovation Promotion Association of the Chinese Academy of Sciences, and was selected as a leading and top talent in Ningbo (second level). Served as a member of the Chinese Anti-Cancer Association, a member of the CTC Technical Expert Committee of the Chinese Anti-Cancer Association, a member of the Sino-American Society of Nanomedicine and Nanobiotechnology, a member of the editorial board of the International Journal of Medical Nano Research, and a journal of Biochemical and Biophysical Journal of Neutron Therapy & Cancer Treatments Member of the editorial advisory board.